Construction of a eukaryotic expression system for granulysin and its protective effect in mice infected with Mycobacterium tuberculosis

References

1. Gamen S., Hanson D. A., Kaspar A., Naval J., Krensky A. M., Anel A. 1998; Granulysin-induced apoptosis.I. Involvement of at least two distinct pathways. J Immunol 161:1758–1764
   [Google Scholar]
2. Honcock R. E. W. 1997; Peptide antibiotics. Lancet 349:418–22 [CrossRef]
   [Google Scholar]
3. Jongstra J., Schall T. J., Dyer B. J., Clayberger C., Jorgensen J., Davis M. M., Krensky A. M. 1987; The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med 165:601–614 [CrossRef]
   [Google Scholar]
4. Julian P., Patricia P. G., Gamen S. & 8 other authors; 2001; A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J Immunol 167:1222–1229 [CrossRef]
   [Google Scholar]
5. Kaspar A. A., Okada S., Kumar J. 2001; A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol 167:350–356 [CrossRef]
   [Google Scholar]
6. Ken D., Clifton E. B. 2004; Prospects for new antitubercular drugs. Curr Opin Microbiol 7:460–465 [CrossRef]
   [Google Scholar]
7. Kim S., Kim S. S., Bang Y. J., Kim S. J., Lee B. J. 2003; In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. Peptides 24:945–953 [CrossRef]
   [Google Scholar]
8. Lehrer R., Ganz T. 1999; Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11:23–27 [CrossRef]
   [Google Scholar]
9. Ma L. L., Spurrell J. C. L., Wang J. F., Neely G. G., Epelman S., Krensky A. M., Mody C. H. 2002; CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. J Immunol 169:5787–5795 [CrossRef]
   [Google Scholar]
10. Manning W. C., O'Farrell S., Goralski T. J., Krensky A. M. 1992; Genomic structure and alternative spilicing of 519, a gene expressed later after T cell activation. J Immunol 148:4036–4042
    [Google Scholar]
11. Marting E. 2001; Driving a stake into resurgent TB. Science 293:234–235 [CrossRef]
    [Google Scholar]
12. Pena S. V., Krensky A. M. 1997; Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol 9:117–125 [CrossRef]
    [Google Scholar]
13. Pena S. V., Hason D. A., Carr B. A., Goralski T. J., Krensky A. M. 1997; Processing subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol 158:2680–2688
    [Google Scholar]
14. Stenger S., Hanson D. A., Teitelbaum R. & 11 other authors; 1998; An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121–125 [CrossRef]
    [Google Scholar]
15. Stenger S., Rosat J.-P., Bloom B. R., Krensky A. M., Modlin R. L. 1999; Granulysin: a lethal weapon of cytolytic T cells. Immunol Today 20:390–394 [CrossRef]
    [Google Scholar]